| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sr. VP, Gen Counsel, and Sec.
1 company
John Adam Zangerle is Sr. VP, Gen Counsel, and Sec. at STE. John Adam Zangerle's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $8.7M at current prices.
Historically, John Adam Zangerle's trades have earned a middling insider score of 55/100 across 5 rated trades. Over a 12-month horizon, 66.7% of those trades were profitable, with an average 12-month return of +11.3%.
The STE filings lean toward selling, a net 48,808 shares.
John Adam Zangerle has 37 Form 4 filings on record from March 2019 to June 2026, all as Sr. VP, Gen Counsel, and Sec. at Steris (STE), 2019–2026.
The 66 reported transactions were 24 tax withholdings, 15 option or other derivative awards, 11 open-market sales and 10 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 10 sales worth about $10.7M.
The largest open-market sale was 15,000 shares of STE at an average $265.14 on November 11, 2025, about $4.0M.
2 of the 3 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other was not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | STE Steris Plc | Sr. VP, Gen Counsel, and Sec. | Sell10b5-1 | 1,419 | $209.28 | $296,968.32 | -3.9% | +3.8% | - | |
| Nov 11, 2025 | STE Steris Plc | Sr. VP, Gen Counsel, and Sec. | Sale+OE | 15,000 | $265.14 | $3,977,100.00 | -30.8% | -8.0% | - | |
| Jun 13, 2025 | STE Steris Plc | Sr. VP, Gen Counsel, and Sec. | Sell10b5-1 | 1,978 | $241.45 | $477,581.18 | -5.5% | +4.6% | -14.0% | |
| Jun 15, 2022 | STE Steris Plc | Sr. VP, Gen Counsel, and Sec. | Sell | 2,659 | $205.31 | $545,919.29 | -8.7% | +1.7% | +6.1% | |
| Apr 20, 2022 | STE Steris Plc | Sr. VP, Gen Counsel, and Sec. | Sale+OE | 8,000 | $255.48 | $2,043,876.00 | -20.5% | -15.6% | -26.2% | |
| Oct 1, 2020 | STE Steris Plc | Sr. VP, Gen Counsel, and Sec. | Sale+OE | 12,252 | $178.00 | $2,180,856.00 | -29.8% | - | - | |
| Sep 14, 2020 | STE Steris Plc | Sr. VP, Gen Counsel, and Sec. | Sell | 2,000 | $167.00 | $334,000.00 | -6.5% | - | - | |
| Feb 11, 2020 | STE Steris Plc | Sr. VP, Gen Counsel, and Sec. | Sale+OE | 3,000 | $162.00 | $486,000.00 | -9.5% | - | - | |
| Oct 4, 2019 | STE Steris Plc | Sr. VP, Gen Counsel, and Sec. | Sell | 1,000 | $142.15 | $142,150.00 | -3.4% | - | - | |
| May 31, 2019 | STE Steris Plc | Sr. VP, Gen Counsel, and Sec. | Sell | 1,500 | $131.77 | $197,655.00 | -4.5% | - | - |